Vyne Therapeutics Inc
NASDAQ:VYNE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
US |
|
E
|
EDP Energias de Portugal SA
F:EDP
|
PT |
|
Apple Inc
NASDAQ:AAPL
|
US |
|
Brookfield Renewable Partners LP
NYSE:BEP
|
BM |
|
Rayonier Advanced Materials Inc
NYSE:RYAM
|
US |
|
F
|
First National Corp
NASDAQ:FXNC
|
US |
|
B
|
BrainCool AB (publ)
F:5YL
|
SE |
|
T
|
Terreno Realty Corp
F:T37
|
US |
|
A
|
Ageas SA
XMUN:FO4N
|
BE |
|
Amazon.com Inc
NASDAQ:AMZN
|
US |
|
Adaro Energy Indonesia TBK PT
OTC:ADOOY
|
ID |
|
Y
|
Yum! Brands Inc
SWB:TGR
|
US |
|
Carrier Global Corp
NYSE:CARR
|
US |
|
Auckland International Airport Ltd
NZX:AIA
|
NZ |
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
Sagimet Biosciences Inc
F:0O2
|
US |
Bankruptcy Probability
Vyne Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vyne Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
25.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
601.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
315.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
232.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
245.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vyne Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vyne Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
